Opioids and Prescription Drug Overdose Prevention
The misuse of prescription medication and opioid-based drugs has increased significantly over the years to become a public health concern in Connecticut. This misuse or abuse includes taking these medications in higher doses than prescribed, for a purpose other than that for which it was prescribed, or taking a medication that was prescribed for another person or obtained off the streets. Opioid overdose is often characterized by a decrease in breathing rate which if not quickly addressed leads to death.
The CT DPH, Yale School of Medicine, and Boston University School of Medicine are hosting a training entitled: Pain and Addiction: Provider training for safe opioid prescribing and the treatment of opioid use disorder. This full day training consists of 2 parts, Scope of Pain and MAT Waiver Training. The event will take place at the Bond Ballroom in Hartford, CT on November 29, 2018.
SCOPE of Pain is an in-depth training that focuses on effective communication skills and the potential risks and benefits of opioids for managing chronic pain. The training includes the assessment of opioid misuse risk and how to manage opioid therapy including opioid tapers using a patient-centered approach.
The PCSS-MAT Half and Half Medication Assisted Treatment (MAT) waiver training course provides an overview of the FDA-approved medications—buprenorphine, naltrexone, and methadone—prescribed for the treatment of opioid use disorder (OUD). Under the Drug Addiction Treatment Act of 2000 (DATA 2000), physicians are required to complete an eight-hour training to qualify for a waiver to prescribe and dispense buprenorphine. The first portion will be provided in person; the second portion is online.
The target audience includes physicians, advance practice nurses, physician assistants, nurses, dentists, pharmacists and allied healthcare professionals.
CMEs and CNEs will be available. Preregistration is required.
Register through this site: www.scopeofpain.org
Enhanced State Surveillance of Opioid-Involved Morbidity and Mortality
This is a CDC grant-funded program that aims to improve the capacity and ability to collect, analyze, and report, in a more timely manner, the number and rate of opioid-related emergency department visits and opioid overdose deaths. Funding from this grant also supports increasing the amount of complex opioid and drug toxicology testing being ordered by the Office of the Chief Medical Examiner for suspected opioid-involved deaths.
'Change the Script' is a statewide public awareness campaign to help communities address the prescription drug and opioid misuse crisis. In collaboration with the Connecticut Department of Mental Health and Addiction Services (DMHAS), Department of Consumer Protection (DCP), and Department of Children and Families (DCF) , DPH has launched an educational campaign for state residents that helps to increase awareness of the dangers of opioid and prescription drug misuse while focusing on decreasing the stigma of addiction and promoting life saving measures such as naloxone and treatment. The campaign materials available for use include social media messages, PSAs (radio and TV), billboards, posters, and brochures.
"Change the Script" is a toolkit that contains creative materials such as advertisements, posters, billboards, direct-distribution pieces, radio scripts, and other materials that can be co-branded and used locally. Ready-to-use materials that do not require customization are also available for distribution and use at the state level.
"Change the Script RX" is a targeted campaign to prescribers to increase awareness and utilization of the CT Prescription Monitoring and Reporting System (CPMRS). It utilizes digital ads, direct mail, social media, posters, flyers and journal advertising to reach prescribers and pharmacist.
- Mixing opioids with other drugs, particularly alcohol or sedatives.
- Resumption of use after a period of abstinence from opioid use, such as recent release from a rehabilitation center or from incarceration.
- Elderly persons may forget that they already took their medication and accidentally re-take the same medication.
- Younger age, specifically the teens or early 20s exposed to peer pressure or a social environment where there is drug use.
- Face is extremely pale and/or clammy to the touch.
- Body is limp.
- Fingernails or lips have a blue or purple cast.
- Vomiting or making gurgling noises.
- Cannot be awakened from sleep or is unable to speak.
- Breathing is very slow or stopped.
- Heartbeat is very slow or stopped.
What should I do if I see an overdose?
- Call 911 immediately!
- Support the person’s breathing.
- Administer naloxone (Narcan) if you have it.
- Lay the person on their side once they have resumed breathing.
- Stay with the overdosed person until the ambulance arrives.
Voluntary Opioid Opt-Out Form:
A person who does not wish to be issued a prescription or medication order for an opioid drug may file this Form with their healthcare provider. Upon receipt of the Form from the patients, a healthcare practitioner shall document receipt of the Form in the patient's medical record.
- Opt-Out/Voluntary NonOpioid Directive Form
- Opioid Opt-Out Form Patient Guide Brochure
- Provider Guidance
Using Naloxone to Reverse an Opioid Overdose: http://www.ctvideo.ct.gov/dmhas/NaloxoneTraining.wmv
For more information, please call
The Office of Injury Prevention